---
id: 013
title: Carbapenemase Classification (KPC vs MBL vs OXA)
category: antimicrobials
subcategory: carbapenemases
tags: [carbapenemase, KPC, MBL, NDM, resistance]
difficulty: hard
---

## Question

Compare the three major classes of carbapenemases: **Serine carbapenemases (KPC)**, **Metallo-β-lactamases (MBL)**, and **OXA-type enzymes**. How do you distinguish them clinically?

## Answer

| Feature | Serine (KPC) | Metallo-β-lactamases (MBL) | OXA Enzymes |
|---------|--------------|----------------------------|-------------|
| **Molecular Class** | Class A | Class B | Class D |
| **Bush-Jacoby** | Group 2f | Group 3a | Group 2df |
| **Mechanism** | Serine-based | Zinc-dependent (Zn²⁺) | Serine-based |
| **Inhibited by clavulanate?** | Partially | No | No |
| **Inhibited by EDTA/zinc chelators?** | No | **YES** | No |
| **Aztreonam susceptibility?** | Resistant | **SUSCEPTIBLE** | Resistant |
| **Major examples** | KPC-2, KPC-3 | NDM-1, VIM-1, IMP-1 | OXA-48, OXA-181 |
| **Geographic notes** | Common in U.S. (*Klebsiella*) | Global spread (NDM from India) | Endemic Europe/Mediterranean |

## Key Points

### **Clinical Testing Clues:**
- **MBL suspected:** Aztreonam-susceptible carbapenem-resistant isolate
- **OXA-48 suspected:** May appear "carbapenem-susceptible" by standard MIC (ertapenem more sensitive)
- **KPC:** Often high-level carbapenem resistance, ceftazidime-avibactam effective

### **Treatment Implications:**
- **KPC:** Ceftazidime-avibactam, meropenem-vaborbactam
- **MBL:** Aztreonam + ceftazidime-avibactam combination (synergy)
- **OXA-48:** Cefiderocol, combination therapy

## Sources

- [PMC1932750: Carbapenemases: the Versatile β-Lactamases]
- [Journal of Intensive Care 2020: Molecular diversity of carbapenemases]
- [PMC2825993: Bush-Jacoby Classification Update]

## Media

N/A
